September 2026
The infectious disease immunoassay market size stood at USD 3.22 billion in 2026, with major infectious disease immunoassay market companies including Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers AG, Beckman Coulter, Inc.
September 2026
The infectious disease vaccines market size reached USD 41.60 billion in 2026, with leading infectious disease vaccines market companies including Pfizer, Moderna, Johnson & Johnson (Janssen), GlaxoSmithKline (GSK).
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 37.98 billion in 2026 with a CAGR of 7.22%.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
August 2025
The global antibody ELISA kits for tropical infectious disease market size was valued at USD 2.39 billion in 2024 and is expected to hit around USD 4.41 billion by 2034, growing at a CAGR of 6.32%.
September 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
September 2026
The global fabry disease treatment market size reached USD 2.65 billion in 2026 and is estimated to hit around USD 5.20 billion by 2035 with a CAGR of 7.82%.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The celiac disease treatment market was valued at USD 879.06 million in 2026, with leading companies including Takeda Pharmaceutical Company Limited, Amgen Inc.
September 2026
The rare diseases treatment market size was estimated at USD 266.68 billion in 2026and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The global chronic disease management market size was estimated at USD 7.51 billion in 2026 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
September 2026
The global respiratory disease vaccine market size was calculated at USD 103.17 billion in 2026 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
September 2026
The end stage renal disease market was valued at USD 174.43 billion in 2026, with end stage renal disease market leading companies including Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc.,Medtronic Plc.
September 2026
The predictive disease analytics market size reached USD 5.81 billion in 2026 and is expected to be worth around USD 23.08 billion by 2035 with a CAGR of 16.6%.
September 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2026 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
September 2026
The global artificial intelligence (AI) in inflammatory bowel disease market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2026 to 2034.
September 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.37 billion in 2026, with a CAGR of 5.02%.
September 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 4.35 billion in 2026 with a CAGR of 15.48%.
September 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
September 2026
The global chemiluminescence immunoassay market size is projected to hit around USD 17.24 billion by 2035 from USD 9.01 billion in 2026 with a CAGR of 7.49%.
September 2026
The lyme disease diagnostic devices market size accounted for USD 2.97 billion in 2026 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
September 2026
The global periodontal disease treatment market size was evaluated at USD 3.17 billion in 2026 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com